Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
BMC Med Genomics. 2022 Feb 1;15(1):18. doi: 10.1186/s12920-022-01165-4.
Hereditary hearing loss (HHL) is a common heterogeneous disorder affecting all ages, ethnicities, and genders. The most common form of HHL is autosomal recessive non-syndromic hearing loss (ARNSHL), in which there is no genotype-phenotype correlation in the majority of cases. This study aimed to identify the genetic causes of hearing loss (HL) in a family with Iranian Azeri Turkish ethnicity negative for gap junction beta-2 (GJB2), gap junction beta-6 (GJB6), and mitochondrially encoded 12S rRNA (MT-RNR1) deleterious mutations.
Targeted genome sequencing method was applied to detect genetic causes of HL in the family. Sanger sequencing was employed to verify the segregation of the variant. Finally, we used bioinformatics tools and American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) guidelines to determine whether the detected variant might affect the corresponding protein or not.
A novel homozygous missense mutation, c.499G>A (p.G167R), was identified in exon 5 of the ESRRB (estrogen-related receptor beta) gene. Healthy and affected family members confirmed the co-segregation of the variant with ARNSHL. Eventually, the variant's pathogenicity was confirmed by the in silico analysis and the ACMG/AMP guidelines.
The study suggests that the detected variant, c.499G>A, plays a crucial role in the development of ARNSHL, emphasizing the clinical significance of the ESRRB gene in ARNSHL patients. Additionally, it would be helpful for genetic counseling and clinical management of ARNSHL patients and providing preventive opportunities.
遗传性听力损失(HHL)是一种常见的异质性疾病,影响所有年龄段、种族和性别。最常见的 HHL 形式是常染色体隐性非综合征性听力损失(ARNSHL),在大多数情况下,没有基因型-表型相关性。本研究旨在确定一个具有伊朗阿塞拜疆土耳其血统的家族的听力损失(HL)的遗传原因,该家族的 GJB2、GJB6 和线粒体编码 12S rRNA(MT-RNR1)有害突变均为阴性。
应用靶向基因组测序方法检测家族中 HL 的遗传原因。采用 Sanger 测序验证变异的分离。最后,我们使用生物信息学工具和美国医学遗传学与基因组学学院/分子病理学协会(ACMG/AMP)指南来确定所检测到的变异是否可能影响相应的蛋白质。
在 ESRRB(雌激素相关受体β)基因的外显子 5 中发现了一个新的纯合错义突变 c.499G>A(p.G167R)。健康和受影响的家庭成员证实了该变异与 ARNSHL 的共分离。最终,通过计算机分析和 ACMG/AMP 指南证实了该变异的致病性。
该研究表明,所检测到的变异 c.499G>A 在 ARNSHL 的发展中起着关键作用,强调了 ESRRB 基因在 ARNSHL 患者中的临床意义。此外,这将有助于对 ARNSHL 患者进行遗传咨询和临床管理,并提供预防机会。